International Advisory Group
The international Advisory Group for the programme consists of leading experts providing expertise in both the research and treatment of prostate cancer and the design and conduct of meta-analyses. The Programme Management Group will draw on their expertise in making important and strategic decisions. Together they will be jointly responsible for the oversight of the programme to ensure planned objectives are achieved. The Programme Management Group and the international Advisory Group will also work closely with key collaborators.
Christopher Sweeney
Clinical advisor
South Australian Immunogenomics Cancer Institute (SAiGENCI)
Faculty of Health and Medical Sciences, University of Adelaide, Australia
Bertrand Tombal
Clinical advisor
Université catholique de Louvain, Cliniques universitaires Saint-Luc, Brussels, Belgium
Mahesh Parmar
Statistical advisor
MRC Clinical Trials Unit and the Institute of Clinical Trials and Methodology at University College London, UK
Ian White
Statistical advisor
MRC Clinical Trials Unit and the Institute of Clinical Trials and Methodology at University College London, UK
Nick James
Clinical Advisor
The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London, UK
Noel Clarke
Clinical Advisor
University of Manchester, Manchester, UK and The Christie Hospital NHS Foundation Trust, Manchester, UK
Gert Attard
Clinical Advisor
Cancer Institute, University College London, London, UK and University College London Hospitals, London, UK